GM, M., R, G., SL, L., B, W., I, L., & FB, N. (2018). Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine. Neurology, 91(17), 797. https://doi.org/10.1212/WNL.0000000000006396
Chicago Style (17th ed.) CitationGM, Moreno, Gandhi R, Lessig SL, Wright B, Litvan I, and Nahab FB. "Mortality in Patients with Parkinson Disease Psychosis Receiving Pimavanserin and Quetiapine." Neurology 91, no. 17 (2018): 797. https://doi.org/10.1212/WNL.0000000000006396.
MLA (9th ed.) CitationGM, Moreno, et al. "Mortality in Patients with Parkinson Disease Psychosis Receiving Pimavanserin and Quetiapine." Neurology, vol. 91, no. 17, 2018, p. 797, https://doi.org/10.1212/WNL.0000000000006396.
Warning: These citations may not always be 100% accurate.